Quantcast

TH302 Clinical Trial


#1

The phase 3 trial is ongoing but not recruiting patient:

https://clinicaltrials.gov/ct2/show/NCT01440088

According to an article from September 2014, results are expected towards the end of 2015:

http://investor.thresholdpharm.com/releasedetail.cfm?ReleaseID=871862

Apparently they are waiting for enough deaths (434) events out of 640 patients.